The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 30, 2018

Filed:

Feb. 20, 2017
Applicant:

Immune Therapeutics Inc., Orlando, FL (US);

Inventors:

Noreen Griffin, Winter Park, FL (US);

Fengping Shan, Shenyang, CN;

Nicholas Plotnikoff, Ocean City, NJ (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61K 31/52 (2006.01); A61K 31/505 (2006.01); A61K 31/485 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 9/70 (2006.01); A61K 31/513 (2006.01); A61K 31/655 (2006.01); A61K 31/337 (2006.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); A61K 9/0053 (2013.01); A61K 9/48 (2013.01); A61K 9/7007 (2013.01); A61K 31/337 (2013.01); A61K 31/513 (2013.01); A61K 31/655 (2013.01); A61K 45/06 (2013.01); A61K 31/505 (2013.01); A61K 31/52 (2013.01);
Abstract

A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.01 and about 10 mg of naltrexone.


Find Patent Forward Citations

Loading…